JPWO2022015110A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2022015110A5 JPWO2022015110A5 JP2023503070A JP2023503070A JPWO2022015110A5 JP WO2022015110 A5 JPWO2022015110 A5 JP WO2022015110A5 JP 2023503070 A JP2023503070 A JP 2023503070A JP 2023503070 A JP2023503070 A JP 2023503070A JP WO2022015110 A5 JPWO2022015110 A5 JP WO2022015110A5
- Authority
- JP
- Japan
- Prior art keywords
- drug
- cancer
- jimt
- tumor
- cells
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR20200088005 | 2020-07-16 | ||
| KR10-2020-0088005 | 2020-07-16 | ||
| KR1020210060721A KR102349925B1 (ko) | 2020-07-16 | 2021-05-11 | Fl118 약물을 포함하는 화합물 및 이를 이용한 면역접합체 |
| KR10-2021-0060721 | 2021-05-11 | ||
| PCT/KR2021/009204 WO2022015110A1 (ko) | 2020-07-16 | 2021-07-16 | Fl118 약물이 산 민감성 링커에 연결된 접합체 및 이를 이용한 면역접합체 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023534292A JP2023534292A (ja) | 2023-08-08 |
| JPWO2022015110A5 true JPWO2022015110A5 (ko) | 2023-09-28 |
Family
ID=79339522
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023503070A Pending JP2023534292A (ja) | 2020-07-16 | 2021-07-16 | Ｆｌ１１８薬物が酸感受性リンカーに結合された複合体及びそれを用いた免疫複合体 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20230270867A1 (ko) |
| EP (1) | EP4183418A1 (ko) |
| JP (1) | JP2023534292A (ko) |
| KR (3) | KR102349925B1 (ko) |
| CN (1) | CN116075321A (ko) |
| AU (1) | AU2021308834A1 (ko) |
| CA (1) | CA3189462A1 (ko) |
| WO (1) | WO2022015110A1 (ko) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20230155992A (ko) * | 2022-05-04 | 2023-11-13 | 주식회사 피노바이오 | Ddx5 단백질에 결합하는 캄토테신계 약물이 산 민감성 링커에 연결된 접합체 및 이를 이용한 면역접합체 |
| WO2024014837A1 (ko) * | 2022-07-11 | 2024-01-18 | 주식회사 피노바이오 | Ddx5 단백질에 결합하는 캄토테신 유도체 및 이의 프로드럭 |
| WO2024049220A1 (ko) * | 2022-08-30 | 2024-03-07 | 주식회사 피노바이오 | 캄토테신계 약물이, 항원 결합 친화도가 낮은 항체에 링커를 통해 연결된 항체-약물 접합체 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103442565B (zh) * | 2010-10-29 | 2016-08-10 | 健康研究股份有限公司 | 使用用于癌症治疗的化合物fl118制剂的非水溶性化合物新型制剂及方法 |
| US10206918B2 (en) * | 2012-12-13 | 2019-02-19 | Immunomedics, Inc. | Efficacy of anti-HLA-DR antiboddy drug conjugate IMMU-140 (hL243-CL2A-SN-38) in HLA-DR positive cancers |
| CN106715443A (zh) * | 2014-03-26 | 2017-05-24 | 坎格特生物技术制药有限责任公司 | Fl118母核化学结构平台产生用于治疗人类疾病的fl118衍生物的用途 |
-
2021
- 2021-05-11 KR KR1020210060721A patent/KR102349925B1/ko active IP Right Grant
- 2021-07-16 US US18/016,331 patent/US20230270867A1/en active Pending
- 2021-07-16 KR KR1020210093769A patent/KR20220009916A/ko not_active Application Discontinuation
- 2021-07-16 EP EP21841752.5A patent/EP4183418A1/en active Pending
- 2021-07-16 AU AU2021308834A patent/AU2021308834A1/en active Pending
- 2021-07-16 JP JP2023503070A patent/JP2023534292A/ja active Pending
- 2021-07-16 CA CA3189462A patent/CA3189462A1/en active Pending
- 2021-07-16 WO PCT/KR2021/009204 patent/WO2022015110A1/ko unknown
- 2021-07-16 CN CN202180062303.4A patent/CN116075321A/zh active Pending
- 2021-10-15 KR KR1020210137595A patent/KR20220009928A/ko active Search and Examination
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2015534577A5 (ko) | ||
| JP2015534578A5 (ko) | ||
| JP2021059564A (ja) | 癌治療のための併用療法 | |
| JP2013520442A5 (ko) | ||
| JP2016502504A5 (ko) | ||
| JP2012046518A5 (ko) | ||
| JP2015534579A5 (ko) | ||
| JP2018527383A5 (ko) | ||
| JP2016520082A5 (ko) | ||
| CN111132696B (zh) | Pd-1抗体和表观遗传调节剂联合在制备治疗肿瘤的药物中的用途 | |
| JP6557744B2 (ja) | 抗腫瘍剤及び抗腫瘍効果増強剤 | |
| WO2013088304A1 (en) | Combination of inotuzumab ozogamicin and torisel for the treatment of cancer | |
| JP2014510080A5 (ko) | ||
| JP2019524713A5 (ko) | ||
| JP2024075639A (ja) | Ｌｉｖ１－ａｄｃ及び化学療法剤を用いた併用療法 | |
| JPWO2022015110A5 (ko) | ||
| RU2657604C2 (ru) | Противоопухолевый агент, включающий гидрат гидрохлорида иринотекана | |
| WO2022051491A1 (en) | Pharmaceutical compositions of tetracyclic quinolone analogs and their salts | |
| CN111093703A (zh) | 免疫治疗剂、核苷类抗代谢物和铂类联合在制备治疗肿瘤的药物中的用途 | |
| CN112543637B (zh) | 伊立替康联合免疫检查点抑制剂和5-fu在制备治疗肿瘤疾病的药物中的用途 | |
| WO2023198079A1 (zh) | 治疗her2阳性实体瘤的方法 | |
| WO2023134706A1 (zh) | 抗trop-2抗体偶联药物和其他治疗剂的组合用途 | |
| TW202330040A (zh) | 抗ｈｅｒ２抗體藥物偶聯物和酪胺酸激酶抑制劑聯合在製備治療腫瘤的藥物中的用途 | |
| RU2021133713A (ru) | Adc для лечения сопутствующе с или после доцетаксела | |
| CN116712539A (zh) | 抗her2抗体药物偶联物和抗pd-1抗体联合在制备治疗肿瘤的药物中的用途 |